TSC is associated with a high sporadic mutation rate, resulting from inactivating variants in TSC1 (OMIM: 191100) and TSC2 (OMIM: 613254) tumor suppressor genes (Curatolo et al., 2015b; Salussolia et al., 2019). Here, TSC2 is linked to neoplasm.